General Information
Revision date
2015-06-09
Product name
Terbinafine Tablets, USP
Product Synonyms
Terbinafine Tablets
Chemical name
1-Naphthalenemethanamine,N-(6,6-dimethyl-2-hepten-4-ynyl)-N- methyl-,(E)-, monohydrochloride
CAS No.
78628-80-5
Emergency telephone
InvaGen Pharmaceuticals Inc
Icons in SDS
Company Information
company name
InvaGen Pharmaceuticals Inc
Section 2
SECTION 2: Hazards identification
OSHA Not considered hazardous when handled under normal conditions. EMERGENCY OVERVIEW Caution Statement: Each Terbinafine Tablets intended for oral administration contains Terbinafine Hydrochloride, USP and excipients generally considered to be non-toxic and non-hazardous in small quantities and under conditions of normal occupational exposure.
Principle Routes of Exposure
Oral Effects of Overexposure: Tablets are intended for human consumption under guidance of a physician. Intact tablets are not considered hazardous under normal handling procedures.
Medical Conditions Generally Aggravated by Exposure
Over exposure by ingestion may cause nausea, vomiting, abdominal pain, dizziness, rash, frequent urination and headache. Carcinogenicity: Terbinafine Hydrochloride - Not listed by IARC, NTP and OSHA.
